 Oyster Point Pharma, Inc. OYST, a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases, today announced that it will report first quarter 2020 financial results on Monday, May 11, 2020, before the market open. The announcement will be followed by a live audio webcast and conference call at 8:00 am Eastern Time. The conference ID number is 6356809. 